AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.

NCT02218047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: Pegylated-Proline-interferon alpha-2b
DRUG: Best available therapy (BAT)

Sponsor

AOP Orphan Pharmaceuticals AG

Collaborators

[object Object]